Over the past few years, there has been a spate of DSL (digital subscriber
line) IPOs. Despite the fact there is a major shift towards broadband, the
DSL market has been tough lately. True, the technology uses existing copper
wire infrastructure. But there are problems. It is not completely
reliable, especially at long distance. Other problems include peak traffic
degradation and cross talk.
In light of this, the Elastic Networks
IPO looked iffy. Although, the company is not a pure
DSL provider; rather it uses advanced Ethernet solutions. The result?
Apparently, the technology cures the many problems with traditional DSL. To
add credibility, the company is a unit of Nortel Networks.
Corporate Europe Observer 5-October 1999::
against genetically modified food and 450 anti-biotech farmers from India on the see the website: http://stad.dsl.nl/~caravan/ Back to Text
http://www.corporateeurope.org/observer5/biotech.htmlHOME |
HickoryTech Installs 10,000th DSL Line::
HickoryTech DSL - speed and simplicity at a competitive cost It is exciting to Healthcare and Biotech. • Retail. • Sports. • Technology
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STOR30-2004/0002554836&EDATE=HOME |
Unfortunately, IPO investors did not seem convinced. The offering price was
$13, as the company raised $85 million. On its first day of trading, the
stock ended up a mere 7%.
Actually, the company looks like a good prospect at these levels, though.
Its patented technology appears to be strong and the backing of Nortel
should lead to strong revenue growth over the long-term.
Another early stage IPO was Genomica
Welcome to WORLDBIOTECHS.COM::
The industry source for semi-solids and liquids. www.dptlabs.com. Biotech Companies DSL. Data Recovery. Health Care. Vitamins. Contact Lenses. Laser Eye
http://www.worldbiotechs.com/HOME |
. The company is a developer of bioinformatics
technologies, which helps to make sense of the billions and billions of DNA
sequences from the human genome. The company's software suite is
comprehensive and is the result of 15 years of research. So far, the
company has been able to attract big customers such as Glaxo Wellcome,
Warner Lambert, the National Cancer Institute, the National Institute of
Health, and Orchid Biosciences.
www.biotechnowlogy.com::
www.umbc.edu/biotech. Biotech Industry DSL. Data Recovery. Health Care. Vitamins. Contact Lenses. Laser Eye Surgery. Cosmetic Surgery
http://www.biotechnowlogy.com/HOME |
Perfect Storm Blog Archive DSLs: specification and behavior::
3/7/08 at Bleeding Edge Biotech said: On 03/07/2008 at 4: Chloroquine malaria treatment and Groovy (DSL tactics in Groovy 2) DSL tactics in Groovy (1/many)
http://tiago.org/ps/2008/03/03/dsls-specification-and-behavior/HOME |
But the IPO was not spectacular. On its first day of trading, the stock was
up 21% (although, the company did raise $122 million). Then again, the
company is in the incipient stage and will take time to see tangible
results.
You can see a more in-depth analysis in a prior IPO Tracker
column.
 E-Mailbag Monday: IPOs, Healtheon, Analysts
 Cable & Wireless Goes VoIP in US $1.4 billion Nortel Deal
|
HOME